Market Cap 2.48B
Revenue (ttm) 182.95M
Net Income (ttm) -115.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -63.16%
Debt to Equity Ratio 0.22
Volume 1,320,200
Avg Vol 704,672
Day's Range N/A - N/A
Shares Out 42.21M
Stochastic %K 93%
Beta 0.81
Analysts Strong Sell
Price Target $74.57

Company Profile

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is also developing TP-04 for the treatment of Ocular Rosacea; TP-05 for potential Lyme disease prophylaxis; and community...

Industry: Biotechnology
Sector: Healthcare
Phone: 949 409 1801
Address:
15440 Laguna Canyon Road, Suite 160, Irvine, United States
MichaelOb
MichaelOb Oct. 5 at 12:13 AM
$TARS so who is buying? someone knows something
0 · Reply
perision
perision Oct. 3 at 9:46 PM
$TARS Excellent chart. Perfect support and bounce at moving averages shows institutions want this higher. Probably $80 by EOY
0 · Reply
NJgolfer
NJgolfer Oct. 3 at 8:09 PM
$TARS big breakout today of Cup with High Handle on 2x higher than avg volume. Expect to see $73 - $74 prior to earnings in a few weeks. Long since $26
0 · Reply
tttggg
tttggg Oct. 3 at 7:39 PM
$TARS ok… the price action is quite unusual.. fingers crossed🤞
1 · Reply
Blazed_Beast
Blazed_Beast Oct. 3 at 4:44 PM
$TARS Finally just hit a new ATH after nearly 5 years! Let's go baby!!
1 · Reply
Blazed_Beast
Blazed_Beast Oct. 3 at 4:27 PM
$TARS Can we get a new new ATH today? So close. Old one is $63.68. We're almost there!
0 · Reply
Hottehueh
Hottehueh Oct. 3 at 3:59 PM
$TARS yepp!
1 · Reply
making_money81
making_money81 Oct. 3 at 3:15 PM
$TARS feels good up here!!
0 · Reply
Doozio
Doozio Oct. 3 at 2:45 PM
$TARS 🐑 about to be feathered. Need a faatch 💣 to save them.
1 · Reply
RonIsWrong
RonIsWrong Oct. 3 at 2:41 PM
$TARS worth the wait
1 · Reply
Latest News on TARS
Tarsus to Participate in Upcoming Investor Conferences

Aug 27, 2025, 5:00 PM EDT - 5 weeks ago

Tarsus to Participate in Upcoming Investor Conferences


Top 2 Health Care Stocks That May Fall Off A Cliff In August

Aug 20, 2025, 8:46 AM EDT - 6 weeks ago

Top 2 Health Care Stocks That May Fall Off A Cliff In August

PINC


Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off

May 12, 2025, 12:28 PM EDT - 5 months ago

Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off


Tarsus Announces Proposed $100.0 Million Public Offering

Mar 12, 2025, 4:12 PM EDT - 7 months ago

Tarsus Announces Proposed $100.0 Million Public Offering


Tarsus Pharma: Strong Execution In Xdemvy Commercialization

Mar 11, 2025, 12:36 PM EDT - 7 months ago

Tarsus Pharma: Strong Execution In Xdemvy Commercialization


Tarsus to Participate in Upcoming Investor Conference

Mar 6, 2025, 5:00 PM EST - 7 months ago

Tarsus to Participate in Upcoming Investor Conference


Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer

Nov 5, 2024, 8:30 AM EST - 11 months ago

Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer


Tarsus to Participate at Upcoming Investor Conferences

Mar 5, 2024, 4:30 PM EST - 1 year ago

Tarsus to Participate at Upcoming Investor Conferences


Tarsus Announces Pricing of $100.0 Million Public Offering

Mar 1, 2024, 12:07 AM EST - 1 year ago

Tarsus Announces Pricing of $100.0 Million Public Offering


MichaelOb
MichaelOb Oct. 5 at 12:13 AM
$TARS so who is buying? someone knows something
0 · Reply
perision
perision Oct. 3 at 9:46 PM
$TARS Excellent chart. Perfect support and bounce at moving averages shows institutions want this higher. Probably $80 by EOY
0 · Reply
NJgolfer
NJgolfer Oct. 3 at 8:09 PM
$TARS big breakout today of Cup with High Handle on 2x higher than avg volume. Expect to see $73 - $74 prior to earnings in a few weeks. Long since $26
0 · Reply
tttggg
tttggg Oct. 3 at 7:39 PM
$TARS ok… the price action is quite unusual.. fingers crossed🤞
1 · Reply
Blazed_Beast
Blazed_Beast Oct. 3 at 4:44 PM
$TARS Finally just hit a new ATH after nearly 5 years! Let's go baby!!
1 · Reply
Blazed_Beast
Blazed_Beast Oct. 3 at 4:27 PM
$TARS Can we get a new new ATH today? So close. Old one is $63.68. We're almost there!
0 · Reply
Hottehueh
Hottehueh Oct. 3 at 3:59 PM
$TARS yepp!
1 · Reply
making_money81
making_money81 Oct. 3 at 3:15 PM
$TARS feels good up here!!
0 · Reply
Doozio
Doozio Oct. 3 at 2:45 PM
$TARS 🐑 about to be feathered. Need a faatch 💣 to save them.
1 · Reply
RonIsWrong
RonIsWrong Oct. 3 at 2:41 PM
$TARS worth the wait
1 · Reply
Hawksssss
Hawksssss Oct. 3 at 1:59 PM
$TARS another all time high
1 · Reply
SqueezeFinder1
SqueezeFinder1 Oct. 3 at 11:50 AM
Good morning, SqueezeFinders! 4. $TARS Squeezability Score: 54% Juice Target: 119.4 Confidence: 🍊 🍊 🍊 Price: 58.77 (+2.49%) Breakdown point: 52.0 Breakout point: 63.7 Mentions (30D): 8 Event/Condition: Potential long-term cup & handle technical pattern playing out + Strong recent earnings report numbers (revenue grew 152% YoY) + New price target 🎯 of $75 from Oppenheimer + Company delivered record results of more than $100 million in net sales and approximately 91,000 bottles dispensed to patients in need. 5. $MNMD Squeezability Score: 54% Juice Target: 23.3 Confidence: 🍊 🍊 Price: 12.22 (-0.89%) Breakdown point: 10.5 Breakout point: 12.7 Mentions (30D): 4 Event/Condition: Recent headline, “RFK Jr. and other Trump officials embrace psychedelics after FDA setback” + Recent price target 🎯 of $23 from Evercore ISI + RFK says “Trump Administration could provide psychedelic therapy to military veterans within 12 months.” Live watchlists, alerts, and more: https://www.squeeze-finder.com/subscribe
1 · Reply
SannieVerraderlijk
SannieVerraderlijk Oct. 2 at 6:10 PM
$TARS time to break 60
0 · Reply
MichaelOb
MichaelOb Oct. 1 at 5:57 PM
$TARS anyone ever notice how similar Demodex mites are in appearance to a tardigrade? Demodex blepharitis and tardigrades show two very different organisms, though both are microscopic and have eight legs. The similarity ends there; they belong to different classifications and have distinct body shapes and lifestyles. Demodex mites are elongated arachnids that are parasites, whereas tardigrades are plump, barrel-shaped animals from their own unique phylum.
0 · Reply
MichaelOb
MichaelOb Oct. 1 at 5:36 PM
$TARS ERADICATE!!!
0 · Reply
Hawksssss
Hawksssss Sep. 30 at 11:21 PM
$TARS another all time high
0 · Reply
biotrader2324
biotrader2324 Sep. 30 at 9:00 PM
$TARS chart continues to look exactly like VRNA pre buyout. prediction true so far.
1 · Reply
YungBullHOLLA
YungBullHOLLA Sep. 30 at 4:57 PM
0 · Reply
Biotechace
Biotechace Sep. 30 at 3:34 PM
$TARS I smell something positive brewing. Buyout? What would a buyout bring? $147 per share?
2 · Reply
RonIsWrong
RonIsWrong Sep. 30 at 2:45 PM
$TARS just a few pennies from a new 52 week high.
1 · Reply
SqueezeFinder1
SqueezeFinder1 Sep. 30 at 1:27 PM
Good morning, SqueezeFinders! 4. $TARS Squeezability Score: 59% Juice Target: 117.8 Confidence: 🍊 🍊 Price: 58.08 (+3.18%) Breakdown point: 50.0 Breakout point: 59.8 Mentions (30D): 6 Event/Condition: Elevated rel vol + Potential long-term cup & handle technical pattern playing out + Strong recent earnings report numbers (revenue grew 152% YoY) 5. $GRAL Squeezability Score: 58% Juice Target: 101.5 Confidence: 🍊 🍊 🍊 Price: 58.77 (+17.87%) Breakdown point: 50.0 Breakout point: 64.0 Mentions (30D): 2 Event/Condition: Rel vol jump + Strong bullish momentum + Potential cup and handle technical pattern playing out + Potentially imminent resumption of long-term uptrend + Company recently announced promising new data from PATHFINDER 2 study on Galleri Multi-Cancer Early Detection Test + Company recently signed a new headquarters lease agreement. Gain access to all our cutting-edge research tools, live watchlists, alerts, and more: https://www.squeeze-finder.com/subscribe
0 · Reply
highnihilism
highnihilism Sep. 30 at 12:22 PM
$IBTA Ibotta Class A: 17 trades, $14.2K vs $56K avg (0.25x). $12.9K calls / $1.2K puts. $LOPE Grand Canyon Education: 18 trades, $13.1K vs $80K avg (0.16x). $12.9K calls / $0.1K puts. $TARS Tarsus Pharma: 22 trades, $16.6K vs $18K avg (0.95x). $12.9K calls / $3.7K puts. $BTCI Neos ETF Trust Neos Bitcoin High Income: 76 trades, $23.9K vs $23K avg (1.03x). $12.9K calls / $11K puts.
0 · Reply